These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 33214214

  • 1. Specific Lowering of Asymmetric Dimethylarginine by Pharmacological Dimethylarginine Dimethylaminohydrolase Improves Endothelial Function, Reduces Blood Pressure and Ischemia-Reperfusion Injury.
    Lee Y, Mehrotra P, Basile D, Ullah M, Singh A, Skill N, Younes ST, Sasser J, Shekhar A, Singh J.
    J Pharmacol Exp Ther; 2021 Feb; 376(2):181-189. PubMed ID: 33214214
    [Abstract] [Full Text] [Related]

  • 2. Increased symmetrical dimethylarginine in ischemic acute kidney injury as a causative factor of renal L-arginine deficiency.
    Betz B, Möller-Ehrlich K, Kress T, Kniepert J, Schwedhelm E, Böger RH, Wanner C, Sauvant C, Schneider R.
    Transl Res; 2013 Aug; 162(2):67-76. PubMed ID: 23707198
    [Abstract] [Full Text] [Related]

  • 3. Asymmetric dimethylarginine accumulates in the kidney during ischemia/reperfusion injury.
    Nakayama Y, Ueda S, Yamagishi S, Obara N, Taguchi K, Ando R, Kaida Y, Iwatani R, Kaifu K, Yokoro M, Toyonaga M, Kusumoto T, Fukami K, Okuda S.
    Kidney Int; 2014 Mar; 85(3):570-8. PubMed ID: 24107853
    [Abstract] [Full Text] [Related]

  • 4. A Recombinant Dimethylarginine Dimethylaminohydrolase-1-Based Biotherapeutics to Pharmacologically Lower Asymmetric Dimethyl Arginine, thus Improving Postischemic Cardiac Function and Cardiomyocyte Mitochondrial Activity.
    Lee Y, Singh J, Scott SR, Ellis B, Zorlutuna P, Wang M.
    Mol Pharmacol; 2022 Apr; 101(4):226-235. PubMed ID: 35042831
    [Abstract] [Full Text] [Related]

  • 5. Age-related changes in ADMA-DDAH-NO pathway in rat liver subjected to partial ischemia followed by global reperfusion.
    Trocha M, Merwid-Ląd A, Chlebda-Sieragowska E, Szuba A, Pieśniewska M, Fereniec-Gołębiewska L, Kwiatkowska J, Szeląg A, Sozański T.
    Exp Gerontol; 2014 Feb; 50():45-51. PubMed ID: 24269305
    [Abstract] [Full Text] [Related]

  • 6. Dimethylarginine dimethylaminohydrolase prevents progression of renal dysfunction by inhibiting loss of peritubular capillaries and tubulointerstitial fibrosis in a rat model of chronic kidney disease.
    Matsumoto Y, Ueda S, Yamagishi S, Matsuguma K, Shibata R, Fukami K, Matsuoka H, Imaizumi T, Okuda S.
    J Am Soc Nephrol; 2007 May; 18(5):1525-33. PubMed ID: 17409314
    [Abstract] [Full Text] [Related]

  • 7. Nitric oxide upregulates dimethylarginine dimethylaminohydrolase-2 via cyclic GMP induction in endothelial cells.
    Sakurada M, Shichiri M, Imamura M, Azuma H, Hirata Y.
    Hypertension; 2008 Nov; 52(5):903-9. PubMed ID: 18824664
    [Abstract] [Full Text] [Related]

  • 8. Molecular mechanism for elevation of asymmetric dimethylarginine and its role for hypertension in chronic kidney disease.
    Matsuguma K, Ueda S, Yamagishi S, Matsumoto Y, Kaneyuki U, Shibata R, Fujimura T, Matsuoka H, Kimoto M, Kato S, Imaizumi T, Okuda S.
    J Am Soc Nephrol; 2006 Aug; 17(8):2176-83. PubMed ID: 16807406
    [Abstract] [Full Text] [Related]

  • 9. Regulation of fluid reabsorption in rat or mouse proximal renal tubules by asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase 1.
    Bell T, Araujo M, Luo Z, Tomlinson J, Leiper J, Welch WJ, Wilcox CS.
    Am J Physiol Renal Physiol; 2018 Jul 01; 315(1):F74-F78. PubMed ID: 29513072
    [Abstract] [Full Text] [Related]

  • 10. Overexpression of dimethylarginine dimethylaminohydrolase inhibits asymmetric dimethylarginine-induced endothelial dysfunction in the cerebral circulation.
    Dayoub H, Rodionov RN, Lynch C, Cooke JP, Arning E, Bottiglieri T, Lentz SR, Faraci FM.
    Stroke; 2008 Jan 01; 39(1):180-4. PubMed ID: 18063827
    [Abstract] [Full Text] [Related]

  • 11. Phosphorylation of Nonmuscle Myosin Light Chain Promotes Endothelial Injury in Hyperlipidemic Rats Through a Mechanism Involving Downregulation of Dimethylarginine Dimethylaminohydrolase 2.
    Wu Y, Zhang JJ, Li TB, Liu WQ, Li LS, Luo XJ, Jiang JL, Ma QL, Yang ZC, Peng J.
    J Cardiovasc Pharmacol Ther; 2016 Nov 01; 21(6):536-548. PubMed ID: 26911182
    [Abstract] [Full Text] [Related]

  • 12. Enhancing kidney DDAH-1 expression by adenovirus delivery reduces ADMA and ameliorates diabetic nephropathy.
    Wetzel MD, Gao T, Stanley K, Cooper TK, Morris SM, Awad AS.
    Am J Physiol Renal Physiol; 2020 Feb 01; 318(2):F509-F517. PubMed ID: 31904280
    [Abstract] [Full Text] [Related]

  • 13. Pioglitazone lowers systemic asymmetric dimethylarginine by inducing dimethylarginine dimethylaminohydrolase in rats.
    Wakino S, Hayashi K, Tatematsu S, Hasegawa K, Takamatsu I, Kanda T, Homma K, Yoshioka K, Sugano N, Saruta T.
    Hypertens Res; 2005 Mar 01; 28(3):255-62. PubMed ID: 16097370
    [Abstract] [Full Text] [Related]

  • 14. Involvement of asymmetric dimethylarginine (ADMA) in tubulointerstitial ischaemia in the early phase of diabetic nephropathy.
    Shibata R, Ueda S, Yamagishi S, Kaida Y, Matsumoto Y, Fukami K, Hayashida A, Matsuoka H, Kato S, Kimoto M, Okuda S.
    Nephrol Dial Transplant; 2009 Apr 01; 24(4):1162-9. PubMed ID: 19015171
    [Abstract] [Full Text] [Related]

  • 15. Impact of high salt independent of blood pressure on PRMT/ADMA/DDAH pathway in the aorta of Dahl salt-sensitive rats.
    Cao Y, Mu JJ, Fang Y, Yuan ZY, Liu FQ.
    Int J Mol Sci; 2013 Apr 12; 14(4):8062-72. PubMed ID: 23584024
    [Abstract] [Full Text] [Related]

  • 16. Influence of ezetimibe on ADMA-DDAH-NO pathway in rat liver subjected to partial ischemia followed by global reperfusion.
    Trocha M, Merwid-Ląd A, Sozański T, Ewa Chlebda-Sieragowska E, Szuba A, Dzięgiel P, Pieśniewska M, Fereniec-Gołębiewska L, Kwiatkowska J, Gomułkiewicz A, Cwynar-Zając Ł, Brykner R, Szeląg A.
    Pharmacol Rep; 2013 Apr 12; 65(1):122-33. PubMed ID: 23563030
    [Abstract] [Full Text] [Related]

  • 17. Changes in ADMA/DDAH pathway after hepatic ischemia/reperfusion injury in rats: the role of bile.
    Ferrigno A, Rizzo V, Bianchi A, Di Pasqua LG, Berardo C, Richelmi P, Vairetti M.
    Biomed Res Int; 2014 Apr 12; 2014():627434. PubMed ID: 25243167
    [Abstract] [Full Text] [Related]

  • 18. Impaired nitric oxide synthase pathway in diabetes mellitus: role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase.
    Lin KY, Ito A, Asagami T, Tsao PS, Adimoolam S, Kimoto M, Tsuji H, Reaven GM, Cooke JP.
    Circulation; 2002 Aug 20; 106(8):987-92. PubMed ID: 12186805
    [Abstract] [Full Text] [Related]

  • 19. Evidence for dysregulation of dimethylarginine dimethylaminohydrolase I in chronic hypoxia-induced pulmonary hypertension.
    Millatt LJ, Whitley GS, Li D, Leiper JM, Siragy HM, Carey RM, Johns RA.
    Circulation; 2003 Sep 23; 108(12):1493-8. PubMed ID: 12952847
    [Abstract] [Full Text] [Related]

  • 20. Dimethylarginine dimethylaminohydrolase overexpression ameliorates atherosclerosis in apolipoprotein E-deficient mice by lowering asymmetric dimethylarginine.
    Jacobi J, Maas R, Cardounel AJ, Arend M, Pope AJ, Cordasic N, Heusinger-Ribeiro J, Atzler D, Strobel J, Schwedhelm E, Böger RH, Hilgers KF.
    Am J Pathol; 2010 May 23; 176(5):2559-70. PubMed ID: 20348244
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.